CD34 and essential thrombocythemia: More similar median levels of circulating CD34+ cells in PV and ET have been observed in another study: 8.9 × 106/L (0–31) in those with PV, 4.1 × 106/L (0–18) in those with ET, and 60 × 106/L (11–449) in PMF patients [17].